17-74748772-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_004252.5(NHERF1):​c.-75G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0271 in 1,335,408 control chromosomes in the GnomAD database, including 638 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.021 ( 49 hom., cov: 33)
Exomes 𝑓: 0.028 ( 589 hom. )

Consequence

NHERF1
NM_004252.5 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.497

Publications

5 publications found
Variant links:
Genes affected
NHERF1 (HGNC:11075): (NHERF family PDZ scaffold protein 1) This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009]
SLC9A3R1-AS1 (HGNC:55322): (SLC9A3R1 antisense RNA 1)
MIR3615 (HGNC:38905): (microRNA 3615) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 17-74748772-G-A is Benign according to our data. Variant chr17-74748772-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1315840.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.021 (3201/152254) while in subpopulation NFE AF = 0.0323 (2197/67990). AF 95% confidence interval is 0.0312. There are 49 homozygotes in GnomAd4. There are 1480 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 3201 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004252.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NHERF1
NM_004252.5
MANE Select
c.-75G>A
5_prime_UTR
Exon 1 of 6NP_004243.1O14745-1
SLC9A3R1-AS1
NR_187307.1
n.961C>T
non_coding_transcript_exon
Exon 2 of 3
MIR3615
NR_037409.1
n.*73G>A
downstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NHERF1
ENST00000262613.10
TSL:1 MANE Select
c.-75G>A
5_prime_UTR
Exon 1 of 6ENSP00000262613.5O14745-1
NHERF1
ENST00000851804.1
c.-75G>A
5_prime_UTR
Exon 1 of 7ENSP00000521863.1
NHERF1
ENST00000851803.1
c.-75G>A
5_prime_UTR
Exon 1 of 6ENSP00000521862.1

Frequencies

GnomAD3 genomes
AF:
0.0210
AC:
3202
AN:
152136
Hom.:
49
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00591
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0246
Gnomad ASJ
AF:
0.0550
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.00942
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.0323
Gnomad OTH
AF:
0.0210
GnomAD4 exome
AF:
0.0279
AC:
32978
AN:
1183154
Hom.:
589
Cov.:
16
AF XY:
0.0275
AC XY:
16148
AN XY:
587336
show subpopulations
African (AFR)
AF:
0.00520
AC:
141
AN:
27136
American (AMR)
AF:
0.0174
AC:
544
AN:
31314
Ashkenazi Jewish (ASJ)
AF:
0.0566
AC:
1310
AN:
23142
East Asian (EAS)
AF:
0.000202
AC:
7
AN:
34658
South Asian (SAS)
AF:
0.00789
AC:
590
AN:
74758
European-Finnish (FIN)
AF:
0.0132
AC:
438
AN:
33160
Middle Eastern (MID)
AF:
0.0227
AC:
120
AN:
5298
European-Non Finnish (NFE)
AF:
0.0315
AC:
28487
AN:
903078
Other (OTH)
AF:
0.0265
AC:
1341
AN:
50610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1603
3206
4808
6411
8014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1034
2068
3102
4136
5170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0210
AC:
3201
AN:
152254
Hom.:
49
Cov.:
33
AF XY:
0.0199
AC XY:
1480
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00589
AC:
245
AN:
41572
American (AMR)
AF:
0.0246
AC:
376
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0550
AC:
191
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5148
South Asian (SAS)
AF:
0.00476
AC:
23
AN:
4832
European-Finnish (FIN)
AF:
0.00942
AC:
100
AN:
10616
Middle Eastern (MID)
AF:
0.0171
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
0.0323
AC:
2197
AN:
67990
Other (OTH)
AF:
0.0208
AC:
44
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
161
322
483
644
805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0235
Hom.:
6
Bravo
AF:
0.0215
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
4.2
DANN
Benign
0.88
PhyloP100
-0.50
PromoterAI
-0.025
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117393174; hg19: chr17-72744911; API